chr8-76984088-G-A
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000318.3(PEX2):c.91C>T(p.Gln31*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000411 in 1,460,260 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. Q31Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_000318.3 stop_gained
Scores
Clinical Significance
Conservation
Publications
- peroxisome biogenesis disorderInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- peroxisome biogenesis disorder 5A (Zellweger)Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, G2P
- peroxisome biogenesis disorder 5BInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- Zellweger spectrum disordersInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000318.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PEX2 | NM_000318.3 | MANE Select | c.91C>T | p.Gln31* | stop_gained | Exon 4 of 4 | NP_000309.2 | ||
| PEX2 | NM_001079867.2 | c.91C>T | p.Gln31* | stop_gained | Exon 3 of 3 | NP_001073336.2 | |||
| PEX2 | NM_001172086.2 | c.91C>T | p.Gln31* | stop_gained | Exon 5 of 5 | NP_001165557.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PEX2 | ENST00000357039.9 | TSL:1 MANE Select | c.91C>T | p.Gln31* | stop_gained | Exon 4 of 4 | ENSP00000349543.4 | ||
| PEX2 | ENST00000522527.5 | TSL:1 | c.91C>T | p.Gln31* | stop_gained | Exon 3 of 3 | ENSP00000428638.1 | ||
| PEX2 | ENST00000520103.5 | TSL:2 | c.91C>T | p.Gln31* | stop_gained | Exon 3 of 3 | ENSP00000428590.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152098Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000400 AC: 1AN: 250288 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1460260Hom.: 0 Cov.: 35 AF XY: 0.00000138 AC XY: 1AN XY: 726314 show subpopulations
Age Distribution
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000657 AC: 1AN: 152098Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74292 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
Age Distribution
ClinVar
Submissions by phenotype
Peroxisome biogenesis disorder 5A (Zellweger) Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the PEX2 protein in which other variant(s) (p.Lys215Serfs*2) have been determined to be pathogenic (PMID: 10652207; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 1454128). This variant has not been reported in the literature in individuals affected with PEX2-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.003%). This sequence change creates a premature translational stop signal (p.Gln31*) in the PEX2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 275 amino acid(s) of the PEX2 protein.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at